Trial intelligence / Profile preview

Tirofiban in Aspirin/Clopidogrel Resistant PCI Patients

NCT00398463Phase 4Completed

Sponsor
University of Ferrara
Start
May 2006
Primary completion
Jul 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in coronary artery disease (CAD) comparing Tirofiban with Placebo (2 arms). Primary endpoint: Troponin I or T elevation ratio at 48 hours. Started May 2006; status: completed.

02

Drugs

tirofiban
03

Conditions

coronary artery disease (CAD)

Beyond the preview

Go deeper on NCT00398463.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00398463.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call